Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension

Hypertension. 1997 Nov;30(5):1223-31. doi: 10.1161/01.hyp.30.5.1223.

Abstract

Previous blood flow studies demonstrated that arginine vasopressin (AVP) produces exaggerated renal vasoconstriction in young spontaneously hypertensive rats (SHR) compared with Wistar-Kyoto control rats (WKY). The purpose of the present study was to determine the role of postreceptor calcium signaling pathways in AVP-induced renal vasoconstriction in vivo. Renal blood flow (RBF) was measured by electromagnetic flowmetry in anesthetized, water-loaded, 8-week-old WKY and SHR pretreated with indomethacin to avoid interactions with prostaglandins. AVP was injected into the renal artery to produce a transient 25% to 30% decrease in RBF without affecting arterial pressure. To achieve similar control levels of vasoconstriction, SHR received a lower dose (2 versus 5 ng). Coadministration of nifedipine with AVP produced dose-dependent inhibition of the AVP-induced renal vasoconstriction. Nifedipine exerted maximum inhibition by blocking 30% to 35% of the peak AVP response, indicating the involvement of dihydropyridine-sensitive voltage-dependent calcium channels. To evaluate intracellular calcium mobilization, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) or heparin was coadministered with AVP. Each agent produced a dose-dependent inhibition of up to 65% of the maximum blood flow change produced by AVP. The degrees of inhibition produced by maximum effective doses of nifedipine and TMB-8 were additive; the combination blocked up to 85% of the response to AVP. These observations indicate that about one third of the AVP-induced constriction of renal resistance vessels is mediated by voltage-dependent L-type calcium channels responsive to the dihydropyridine nifedipine. Approximately two thirds of the change in vascular tone is due to inositol 1,4,5-trisphosphate-mediated calcium mobilization from intracellular sources sensitive to TMB-8 and heparin. The results suggest that the exaggerated renal vascular reactivity to AVP challenge in SHR is probably not due to a strain difference in postreceptor calcium signal transduction. After AVP receptor stimulation, calcium mobilization and calcium entry signaling pathways participate to similar degrees in WKY and SHR.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arginine Vasopressin / pharmacology*
  • Calcium / physiology*
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Gallic Acid / analogs & derivatives
  • Gallic Acid / pharmacology
  • Heparin / pharmacology
  • Hypertension / genetics
  • Hypertension / physiopathology*
  • Injections, Intra-Arterial
  • Nifedipine / pharmacology
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Renal Circulation / drug effects
  • Renal Circulation / physiology*
  • Signal Transduction / physiology*
  • Vasoconstriction / drug effects
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Drug Combinations
  • Vasoconstrictor Agents
  • Arginine Vasopressin
  • 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate
  • Gallic Acid
  • Heparin
  • Nifedipine
  • Calcium